CLINICAL_TRIALS
trial_result
· 2019-12-09
Clinical Trial Update: Study of REGN1500 in Participants With Homozygous Familial Hypercholesterolemia (HoFH) [Phase 2]
Summary
Phase 2 trial of REGN1500 in Homozygous Familial Hypercholesterolemia completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Homozygous Familial Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2019-12-09